Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Cash from Financing Activities (2019 - 2025)

Korro Bio's Cash from Financing Activities history spans 7 years, with the latest figure at $380000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 59.23% year-over-year to $380000.0, compared with a TTM value of $685000.0 through Dec 2025, down 99.01%, and an annual FY2025 reading of $685000.0, down 99.01% over the prior year.
  • Cash from Financing Activities for Q4 2025 was $380000.0 at Korro Bio, up from $128000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $144.6 million in Q4 2023, with the low at -$2.2 million in Q3 2023.
  • Average Cash from Financing Activities over 5 years is $13.6 million, with a median of $200000.0 recorded in 2022.
  • Year-over-year, Cash from Financing Activities crashed 4014.29% in 2023 and then surged 187755.56% in 2024.
  • Tracing KRRO's Cash from Financing Activities over 5 years: stood at $109000.0 in 2021, then plummeted by 318.35% to -$238000.0 in 2022, then soared by 60851.26% to $144.6 million in 2023, then crashed by 99.36% to $932000.0 in 2024, then tumbled by 59.23% to $380000.0 in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Cash from Financing Activities are $380000.0 (Q4 2025), $128000.0 (Q3 2025), and $5000.0 (Q2 2025).